Cilostazol Reduces PAC-1 Expression on Platelets in Ischemic Stroke

BACKGROUND AND PURPOSE: Cilostazol, a phosphodiesterase III inhibitor, is known to be a useful antiplatelet agent that inhibits the progression of atherosclerosis in ischemic stroke. This study investigated the effects of combining cilostazol with aspirin on the expressions of P-selectin and PAC-1 o...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Su-Yun, Kang, Myong-Jin, Cha, Jae-Kwan
Formato: Texto
Lenguaje:English
Publicado: Korean Neurological Association 2008
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2686855/
https://www.ncbi.nlm.nih.gov/pubmed/19513289
http://dx.doi.org/10.3988/jcn.2008.4.4.148

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2686855/
https://www.ncbi.nlm.nih.gov/pubmed/19513289
http://dx.doi.org/10.3988/jcn.2008.4.4.148

Ejemplares similares